Evidence map›Paper›PMID 32010116›Full record

ArticleFrontiers in microbiology2019

Proteomic Profiling Reveals the Architecture of Granulomatous Lesions Caused by Tuberculosis and

Shintaro Seto, Kozo Morimoto, Tsutomu Yoshida, Miyako Hiramatsu, Minako Hijikata, Toshi Nagata, Fumihito Kikuchi, Yuji Shiraishi, Atsuyuki Kurashima, Naoto Keicho

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. From colonisation to chronicity: adaptation ofMicrobiology (Reading, England) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in immunology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Transcriptional regulatorsMicrobiology spectrum · 2024
    Article
  12. mSystems · 2023
    Article
  13. Drug Resistance and Molecular Characteristics ofJournal of personalized medicine · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. International journal of molecular sciences · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shintaro SetoDepartment of Pathophysiology and Host Defense, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Kozo MorimotoRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Tsutomu YoshidaRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Miyako HiramatsuRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Minako HijikataDepartment of Pathophysiology and Host Defense, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Toshi NagataDepartment of Health Science, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Fumihito KikuchiDepartment of Pathology, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Yuji ShiraishiRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Atsuyuki KurashimaRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Naoto KeichoResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Japan Anti Tuberculosis Association · JPFukujuji Hospital · JPHamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) and

Indexed as

granulomaMycobacterium avium complex lung diseasenecrotic caseumproteomicstuberculosis

Identifiers

PMID32010116
PMCPMC6978656
OpenAlexW2999526980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.